Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -3.437M
June 30, 2026 -1.734M
March 31, 2026 2.909M
December 31, 2025 -6.359M
September 30, 2025 -2.383M
June 30, 2025 -0.942M
March 31, 2025 -2.832M
December 31, 2024 2.225M
September 30, 2024 -1.157M
June 30, 2024 -5.176M
March 31, 2024 -5.019M
December 31, 2023 -16.43M
September 30, 2023 18.75M
Date Value
June 30, 2023 3.878M
March 31, 2023 -0.956M
December 31, 2022 -3.836M
September 30, 2022 -7.282M
June 30, 2022 -3.30M
March 31, 2022 0.884M
December 31, 2021 -3.206M
September 30, 2021 7.102M
June 30, 2021
March 31, 2021
December 31, 2020 5.054M
September 30, 2020 -1.071M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Talphera, Inc. -3.034M
Fortress Biotech, Inc. -6.197M
Relmada Therapeutics, Inc. -12.59M
Turn Therapeutics, Inc. -1.549M
ANI Pharmaceuticals, Inc. 83.79M